6月12日，Praxis Precision Medicines盘中上涨5.81%，报262.38美元/股，成交额939.52万美元。
Praxis Precision Medicines所在的生物科技行业中，个股表现分化，其中Nuvalent跌0.16%，艾伯维公司涨0.70%，安进跌0.38%，吉利德科学跌0.95%，Insmed跌0.24%。
Praxis Precision Medicines是一家临床阶段的生物制药公司，致力于将遗传见解转化为中枢神经系统（CNS）治疗方法的发展，聚焦以神经元失衡为特征的疾病领域。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.